Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins

Virology

Volumn 324, Issue 1, 2004, Pages 165-172

  Beauséjour, Yannick ^b   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

Adhesion; Envelope; gp120; HIV 1; ICAM 1; Infectivity; Integrin; LFA 1

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN GP 41; INTERCELLULAR ADHESION MOLECULE 1; LIGAND;

ADHESION; ARTICLE; CELL ADHESION; EMBRYO; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS ACTIVATION; VIRUS INFECTIVITY;

CELL LINE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INSERTION SEQUENCES;

EID: 2942558670     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.03.029     Document Type: Article

References (60)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59(2):1986;284-291
2. Arthur L.O., Bess J.W. Jr., Sowder R.C. II, Benveniste R.E., Mann D.L., Chermann J.C., Henderson L.E. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science. 258(5090):1992;1935-1938
3. Arthur L.O., Bess J.W. Jr., Urban R.G., Strominger J.L., Morton W.R., Mann D.L., Henderson L.E., Benveniste R.E. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 69(5):1995;3117-3124
4. Barreiro O., Yanez-Mo M., Serrador J.M., Montoya M.C., Vicente-Manzanares M., Tejedor R., Furthmayr H., Sanchez-Madrid F. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J. Cell Biol. 157(7):2002;1233-1245
5. Bazil V., Stefanova I., Hilgert I., Kristofova H., Vanek S., Horejsi V. Monoclonal antibodies against human leucocyte antigens: IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein. Folia Biol. 36(1):1990;41-50
6. Binnerts M.E., van Kooyk Y., Simmons D.L., Figdor C.G. Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur. J. Immunol. 24(9):1994;2155-2160
7. Bounou S., Dumais N., Tremblay M.J. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J. Biol. Chem. 276(9):2001;6359-6369
8. Bounou S., Leclerc J.E., Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T- cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 76(3):2002;1004-1014
9. Cantin R., Fortin J.F., Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. 218(2):1996;372-381
10. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71(3):1997;1922-1930
11. Cantin R., Martin G., Tremblay M.J. A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J. Gen. Virol. 82(Pt. 12):2001;2979-2987
12. Castilletti C., Capobianchi M.R., Fais S., Abbate I., Ficociello B., Ameglio F., Cordiali Fei P., Santini S.M., Dianzani F. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA- DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses. 11(5):1995;547-553
13. Chan W.L., Rodgers A., Grief C., Almond N., Ellis S., Flanagan B., Silvera P., Bootman J., Stott J., Kent K., et al. Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H. AIDS. 9(3):1995;223-228
14. Clapham P.R., McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83(Pt. 8):2002;1809-1829
15. Damsky C.H., Sheffield J.B., Tuszynski G.P., Warren L. Is there a role for actin in virus budding? J. Cell Biol. 75(2 Pt 1):1977;593-605
16. Dick A.D., Pell M., Brew B.J., Foulcher E., Sedgwick J.D. Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease. Aids. 11(14):1997;1699-1708
17. Dimmock N.J. Neutralization of animal viruses. Curr. Top Microbiol. Immunol. 183:1993;1-149
18. Dorfman T., Mammano F., Haseltine W.A., Gottlinger H.G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68(3):1994;1689-1696
19. Edbauer C.A., Naso R.B. Cytoskeleton-associated Pr65gag and assembly of retrovirus temperature- sensitive mutants in chronically infected cells. Virology. 134(2):1984;389-397
20. Fais S., Capobianchi M.R., Abbate I., Castilletti C., Gentile M., Cordiali Fei P., Ameglio F., Dianzani F. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS. 9(4):1995;329-335
21. Fortin J.F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71(5):1997;3588-3596
22. Fortin J.F., Cantin R., Tremblay M.J. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72(3):1998;2105-2112
23. Fortin J.F., Barbeau B., Hedman H., Lundgren E., Tremblay M.J. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology. 257(1):1999;228-238
24. Fortin J.F., Cantin R., Bergeron M.G., Tremblay M.J. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology. 268(2):2000;493-503
25. Freed E.O., Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69(3):1995;1984-1989
26. Freed E.O., Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70(1):1996;341-351
27. Guo M.M., Hildreth J.E. HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses. 11(9):1995;1007-1013
28. Heiska L., Alfthan K., Gronholm M., Vilja P., Vaheri A., Carpen O. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J. Biol. Chem. 273(34):1998;21893-21900
29. Henriksson P., Bosch V. Inhibition of cellular glycoprotein incorporation into human immunodeficiency virus-like particles by coexpression of additional cellular interaction partner. Virology. 251(1):1998;16-21
30. Henriksson P., Pfeiffer T., Zentgraf H., Alke A., Bosch V. Incorporation of wild-type and C-terminally truncated human epidermal growth factor receptor into human immunodeficiency virus-like particles: insight into the processes governing glycoprotein incorporation into retroviral particles. J. Virol. 73(11):1999;9294-9302
31. Karczewski M.K., Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70(1):1996;494-507
32. Kim W., Tang Y., Okada Y., Torrey T.A., Chattopadhyay S.K., Pfleiderer M., Falkner F.G., Dorner F., Choi W., Hirokawa N., Morse H.C. 3rd Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. J. Virol. 72(8):1998;6898-6901
33. Landis R.C., Bennett R.I., Hogg N. A novel LFA-1 activation epitope maps to the I domain. J. Cell Biol. 120(6):1993;1519-1527
34. Lee Y.M., Tang X.B., Cimakasky L.M., Hildreth J.E., Yu X.F. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes. J. Virol. 71(2):1997;1443-1452
35. Liao Z., Roos J.W., Hildreth J.E. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4. AIDS Res. Hum. Retroviruses. 16(4):2000;355-366
36. Liu B., Dai R., Tian C.J., Dawson L., Gorelick R., Yu X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 73(4):1999;2901-2908
37. Luftig R.B., Lupo L.D. Viral interactions with the host-cell cytoskeleton: the role of retroviral proteases. Trends Microbiol. 2(5):1994;178-182
38. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74(7):2000;3264-3272
39. Orentas R.J., Hildreth J.E. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses. 9(11):1993;1157-1165
40. Ott D.E., Coren L.V., Kane B.P., Busch L.K., Johnson D.G., Sowder R.C. 2nd, Chertova E. II, Arthur L.O., Henderson L.E. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70(11):1996;7734-7743
41. Ott D.E., Coren L.V., Johnson D.G., Kane B.P., Sowder R.C., Kim Y.D. II, Fisher R.J., Zhou X.Z., Lu K.P., Henderson L.E. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology. 266(1):2000;42-51
42. Paquette J.S., Fortin J.F., Blanchard L., Tremblay M.J. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J. Virol. 72(11):1998;9329-9336
43. Pearce-Pratt R., Malamud D., Phillips D.M. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 68(5):1994;2898-2905
44. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J. Biol. Chem. 275(29):2000;21785-21788
45. Poon D.T., Coren L.V., Ott D.E. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging. J. Virol. 74(8):2000;3918-3923
46. Posner M.R., Cavacini L.A., Emes C.L., Power J., Byrn R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquired Immune Defic. Syndr. 6(1):1993;7-14
47. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology. 220(2):1996;530-534
48. Rizzuto C.D., Sodroski J.G. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71(6):1997;4847-4851
49. Roos J.W., Maughan M.F., Liao Z., Hildreth J.E., Clements J.E. LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology. 273(2):2000;307-315
50. Sasaki H., Nakamura M., Ohno T., Matsuda Y., Yuda Y., Nonomura Y. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. U.S.A. 92(6):1995;2026-2030
51. Sonza S., Maerz A., Uren S., Violo A., Hunter S., Boyle W., Crowe S. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res. Hum. Retroviruses. 11(7):1995;769-776
52. Springer T.A. Adhesion receptors of the immune system. Nature. 346(6283):1990;425-434
53. Tang Y., Winkler U., Freed E.O., Torrey T.A., Kim W., Li H., Goff S.P., Morse H.C. 3rd Cellular motor protein KIF-4 associates with retroviral Gag. J. Virol. 73(12):1999;10508-10513
54. Tremblay M.J., Fortin J.F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today. 19(8):1998;346-351
55. Ugolini S., Mondor I., Sattentau Q.J. HIV-1 attachment: another look. Trends Microbiol. 7(4):1999;144-149
56. Wilk T., Gowen B., Fuller S.D. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J. Virol. 73(3):1999;1931-1940
57. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393(6686):1998;705-711
58. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91(20):1994;9564-9568
59. Yu X., Yuan X., Matsuda Z., Lee T.H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66(8):1992;4966-4971
60. Yu X., Yuan X., McLane M.F., Lee T.H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67(1):1993;213-221